ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma
September 30, 2020The National Comprehensive Cancer Network® (NCCN®) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma. -
EC expands Takeda’s Adcetris authorisation for Hodgkin lymphoma
February 14, 2019The European Commission (EC) has expanded the marketing authorisation of Takeda Pharmaceutical’s Adcetris (brentuximab vedotin) to adults with previously untreated CD30+ Stage IV Hodgkin lymphoma.... -
NICE recommends against Opdivo for classical Hodgkin lymphoma
March 16, 2017The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab)... -
Hodgkin Lymphoma Survivors Face Risk of Second Cancer: Study
March 14, 2017The risk of developing a second type of cancer may be high among Hodgkin lymphoma survivors, especially those with a family history of cancer.
Pharma Sources Insight January 2025
